Shin S, Kim Y, Oh SC, Yu N, Lee ST, Choi JR, et al. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing. Oncotarget 2017;8:34858–66.Web of SciencePubMedGoogle Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17: 405–24.CrossrefWeb of SciencePubMedGoogle Scholar
Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D, et al. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 1996;12:2507–13.PubMedGoogle Scholar
Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, et al. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 2002;70:858–65.PubMedCrossrefGoogle Scholar
Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609–15.CrossrefPubMedGoogle Scholar
Chong HK, Wang T, Lu HM, Seidler S, Lu H, Keiles S, et al. The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay. PLoS One 2014;9:e97408.PubMedWeb of ScienceCrossrefGoogle Scholar
Gray PN, Dunlop CL, Elliott AM. Not all next generation sequencing diagnostics are created equal: understanding the nuances of solid tumor assay design for somatic mutation detection. Cancers (Basel) 2015;7:1313–32.PubMedCrossrefGoogle Scholar
Silva FC, Torrezan GT, Brianese RC, Stabellini R, Carraro DM. Pitfalls in genetic testing: a case of a SNP in primer-annealing region leading to allele dropout in BRCA1. Mol Genet Genomic Med 2017;5:443–7.PubMedWeb of ScienceCrossrefGoogle Scholar
About the article
Published Online: 2018-10-23
Published in Print: 2019-05-27
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.